Bluefin Capital Management, LLC Galapagos Nv Call Options Transaction History

Bluefin Capital Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$52.3 - $71.59 $7.88 Million - $10.8 Million	-150,700 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $1.45 Million - $1.94 Million	28,300 Added 23.12%	150,700 $302,000
Q4 2021 Feb 14, 2022	BUY	$47.03 - $57.12 $2.23 Million - $2.71 Million	47,400 Added 63.2%	122,400 $46,000
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $3.91 Million - $5.27 Million	75,000 New	75,000 $109,000

12.2M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.5B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.